MorphoSys ADR earnings, Revenue beat in Q2

  • Investing.com
MorphoSys ADR earnings, Revenue beat in Q2

Investing.com - MorphoSys ADR reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.

MorphoSys ADR announced earnings per share of €10.47 on revenue of €100.9M. Analysts polled by Investing.com anticipated EPS of €-0.5273 on revenue of €61.1M.

MorphoSys ADR shares are down 67.11% from the beginning of the year and are trading at €5.74 , down-from-52-week-high.They are under-performing the Nasdaq which is down 19.03% year to date.

MorphoSys ADR follows other major Healthcare sector earnings this month

MorphoSys ADR's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of €5.57 on revenue of €80.33B, compared to forecasts EPS of €5.21 on revenue of €79.68B.

J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of €2.59 on revenue of €24.02B, compared to forecast for EPS of €2.54 on revenue of €23.77B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles